Stock TRPXY THERAPIX BIOSCIENCES LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Therapix Biosciences Ltd. OTC Markets

Equities

TRPXY

US88339A3023

Delayed OTC Markets
Other stock markets
 		5-day change 1st Jan Change
- USD -.--% Intraday chart for Therapix Biosciences Ltd. +27.78% +53.33%
16/07 SciSparc Receives Nasdaq Noncompliance Notice MT
16/07 SciSparc Seeks Patent for Obesity Drug Ingredient's Composition MT

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
SciSparc Signs Non-Binding Letter of Intent for Exclusive Global Out-Licensing of Pain Treatment for Approximately $6 million
GL
SciSparc Receives Nasdaq Noncompliance Notice
MT
SciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification
GL
SciSparc Seeks Patent for Obesity Drug Ingredient's Composition
MT
SciSparc Announces U.S. Patent Application for Treating Metabolic Syndrome and Weight Loss
GL
Clearmind Medicine Announces Submission of US Patent Application for Treating Metabolic Syndrome and Weight-loss
CI
SciSparc Signs Non-Binding Letter of Intent to Spin Off Advanced Clinical Stage Pharmaceutical Portfolio
MT
SciSparc Signs Non-Binding Letter of Intent for Spin Off of Advanced Clinical Stage Pharmaceutical Portfolio to Publicly Traded Company
GL
SciSparc : Report Of Foreign Private Issuer Form 6 K
PU
SciSparc Ltd. Secures Strategic Advantage with Grant of European Patent
CI
SciSparc Secures Strategic Advantage with Grant of European Patent
GL
SciSparc to Acquire AutoMax
GL
SciSparc Ltd. signed a merger agreement to acquire remaining stake in Automax Motors Ltd.
CI
Tranche Update on SciSparc Ltd.'s Equity Buyback Plan announced on July 7, 2022.
CI
SciSparc Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research
GL
SciSparc Granted Another Patent, Strengthening its Core Technology in Canada
GL
SciSparc Granted Another Patent, Strengthening its Core Technology in Canada
AQ
SciSparc Ltd. Receives Another Patent, Strengthening its Core Technology in Canada
CI
SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SPRC Stock
  4. TRPXY Stock
  5. News Therapix Biosciences Ltd.